BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kawasaki S, Imamura H, Kobayashi A, Noike T, Miwa S, Miyagawa S. Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg. 2003;238:84-92. [PMID: 12832969 DOI: 10.1097/01.sla.0000074984.83031.02] [Cited by in Crossref: 143] [Cited by in F6Publishing: 95] [Article Influence: 7.9] [Reference Citation Analysis]
Number Citing Articles
1 Kondo S, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Furuse J, Saito H, Tsuyuguchi T, Yamamoto M, Kayahara M, Kimura F, Yoshitomi H, Nozawa S, Yoshida M, Wada K, Hirano S, Amano H, Miura F; Japanese Association of Biliary Surgery; Japanese Society of Hepato-Biliary-Pancreatic Surgery; Japan Society of Clinical Oncology. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg. 2008;15:41-54. [PMID: 18274843 DOI: 10.1007/s00534-007-1279-5] [Cited by in Crossref: 137] [Cited by in F6Publishing: 115] [Article Influence: 10.5] [Reference Citation Analysis]
2 Caillol F, Bories E, Poizat F, Pesenti C, Esterni B, Monges G, Giovannini M. Endomicroscopy in bile duct: Inflammation interferes with pCLE applied in the bile duct: A prospective study of 54 patients. United European Gastroenterol J. 2013;1:120-127. [PMID: 24917949 DOI: 10.1177/2050640613483462] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
3 Huang JY, Yang WZ, Li JJ, Jiang N, Zheng QB. Portal vein embolization induces compensatory hypertrophy of remnant liver. World J Gastroenterol 2006;12:408-14. [PMID: 16489640 DOI: 10.3748/wjg.v12.i3.408] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
4 Sakamoto Y, Shimada K, Nara S, Esaki M, Ojima H, Sano T, Yamamoto J, Kosuge T. Surgical management of infrahilar/suprapancreatic cholangiocarcinoma: an analysis of the surgical procedures, surgical margins, and survivals of 77 patients. J Gastrointest Surg. 2010;14:335-343. [PMID: 19902311 DOI: 10.1007/s11605-009-1072-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
5 Nimura Y. Preoperative biliary drainage before resection for cholangiocarcinoma (Pro). HPB (Oxford). 2008;10:130-133. [PMID: 18773090 DOI: 10.1080/13651820801992666] [Cited by in Crossref: 75] [Cited by in F6Publishing: 60] [Article Influence: 6.8] [Reference Citation Analysis]
6 Wakai T, Sakata J, Katada T, Hirose Y, Soma D, Prasoon P, Miura K, Kobayashi T. Surgical management of carcinoma in situ at ductal resection margins in patients with extrahepatic cholangiocarcinoma. Ann Gastroenterol Surg 2018;2:359-66. [PMID: 30238077 DOI: 10.1002/ags3.12196] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
7 Kumar S, Masood S, Srivastava U, Madhavan SM, Chauhan S, Pandey A. Factors predicting recovery of liver function after percutaneous drainage in malignant biliary obstruction: the role of hospital-acquired biliary sepsis. Clin Exp Hepatol 2020;6:295-303. [PMID: 33511276 DOI: 10.5114/ceh.2020.102154] [Reference Citation Analysis]
8 Hirose T, Igami T, Ebata T, Yokoyama Y, Sugawara G, Mizuno T, Mori K, Ando M, Nagino M. Surgical and Radiological Studies on the Length of the Hepatic Ducts. World J Surg 2015;39:2983-9. [PMID: 26296838 DOI: 10.1007/s00268-015-3201-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
9 Nagino M. Perihilar cholangiocarcinoma: a surgeon’s viewpoint on current topics. J Gastroenterol. 2012;47:1165-1176. [PMID: 22847554 DOI: 10.1007/s00535-012-0628-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
10 Sakata J, Shirai Y, Tsuchiya Y, Wakai T, Nomura T, Hatakeyama K. Preoperative cholangitis independently increases in-hospital mortality after combined major hepatic and bile duct resection for hilar cholangiocarcinoma. Langenbecks Arch Surg. 2009;394:1065-1072. [PMID: 19169703 DOI: 10.1007/s00423-009-0464-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
11 Sasaki R, Takeda Y, Funato O, Nitta H, Kawamura H, Uesugi N, Sugai T, Wakabayashi G, Ohkohchi N. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg. 2007;31:1788-1796. [PMID: 17647056 DOI: 10.1007/s00268-007-9102-7] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 5.4] [Reference Citation Analysis]
12 Soares KC, Jarnagin WR. The Landmark Series: Hilar Cholangiocarcinoma. Ann Surg Oncol 2021;28:4158-70. [PMID: 33829358 DOI: 10.1245/s10434-021-09871-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Capussotti L, Vigano L, Ferrero A, Muratore A. Local surgical resection of hilar cholangiocarcinoma: is there still a place? HPB (Oxford). 2008;10:174-178. [PMID: 18773049 DOI: 10.1080/13651820801992534] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
14 Fang Y, Gurusamy KS, Wang Q, Davidson BR, Lin H, Xie X, Wang C. Pre-operative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev. 2012;CD005444. [PMID: 22972086 DOI: 10.1002/14651858.cd005444.pub3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
15 Yasuda Y, Larsen PN, Ishibashi T, Yamashita K, Toei H. Resection of hilar cholangiocarcinoma with left hepatectomy after pre-operative embolization of the proper hepatic artery. HPB (Oxford) 2010;12:147-52. [PMID: 20495660 DOI: 10.1111/j.1477-2574.2009.00152.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
16 Zhimin G, Noor H, Jian-Bo Z, Lin W, Jha RK. Advances in diagnosis and treatment of hilar cholangiocarcinoma -- a review. Med Sci Monit. 2013;19:648-656. [PMID: 23921971 DOI: 10.12659/msm.889379] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
17 Tran TB, Dua MM, Spain DA, Visser BC, Norton JA, Poultsides GA. Hepato-pancreatectomy: how morbid? HPB (Oxford). 2015;17:763-769. [PMID: 26058463 DOI: 10.1111/hpb.12426] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
18 Lee SJ, Kwon W, Kang MJ, Jang JY, Chang YR, Jung W, Kim SW. Clinical features and survival outcome of locally advanced extrahepatic cholangiocarcinoma. Korean J Hepatobiliary Pancreat Surg 2014;18:1-8. [PMID: 26155239 DOI: 10.14701/kjhbps.2014.18.1.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Regimbeau JM, Fuks D, Pessaux P, Bachellier P, Chatelain D, Diouf M, Raventos A, Mantion G, Gigot JF, Chiche L. Tumour size over 3 cm predicts poor short-term outcomes after major liver resection for hilar cholangiocarcinoma. By the HC-AFC-2009 group. HPB (Oxford). 2015;17:79-86. [PMID: 24992279 DOI: 10.1111/hpb.12296] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
20 Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H, Nakashima A, Sueda T. Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. J Gastrointest Surg. 2009;13:1470-1479. [PMID: 19421824 DOI: 10.1007/s11605-009-0900-0] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 6.0] [Reference Citation Analysis]
21 Lee Y, Choi D, Han S, Han IW, Heo JS, Choi SH. Comparison analysis of left-side versus right-side resection in bismuth type III hilar cholangiocarcinoma. Ann Hepatobiliary Pancreat Surg 2018;22:350-8. [PMID: 30588526 DOI: 10.14701/ahbps.2018.22.4.350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
22 Ramos E. Principles of surgical resection in hilar cholangiocarcinoma. World J Gastrointest Oncol. 2013;5:139-146. [PMID: 23919108 DOI: 10.4251/wjgo.v5.i7.139] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
23 Xu F, Liu X, Wang C, Dai C. Prostaglandin E1 Preconditioning Attenuates Liver Ischemia Reperfusion Injury in a Rat Model of Extrahepatic Cholestasis. Biomed Res Int 2018;2018:3812424. [PMID: 29511679 DOI: 10.1155/2018/3812424] [Reference Citation Analysis]
24 Wu W, Cheng Q, Chen J, Chen D, Feng X, Wu J. Left-side vs. right-side hepatectomy for hilar cholangiocarcinoma: a meta-analysis. World J Surg Oncol 2021;19:107. [PMID: 33838682 DOI: 10.1186/s12957-021-02213-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Motoyama H, Kobayashi A, Yokoyama T, Shimizu A, Sakai H, Notake T, Fukushima K, Miyagawa SI. Treatment with specific soluble factors promotes the functional maturation of transcription factor-mediated, pancreatic transdifferentiated cells. PLoS One 2018;13:e0197175. [PMID: 29768476 DOI: 10.1371/journal.pone.0197175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Bagante F, Tran T, Spolverato G, Ruzzenente A, Buttner S, Ethun CG, Groot Koerkamp B, Conci S, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Vitiello G, IJzermans JN, Maithel SK, Poultsides G, Guglielmi A, Pawlik TM. Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme. J Am Coll Surg. 2016;222:750-759.e2. [PMID: 27113512 DOI: 10.1016/j.jamcollsurg.2016.02.012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
27 Kimura N, Toyoki Y, Ishido K, Kudo D, Yakoshi Y, Tsutsumi S, Miura T, Wakiya T, Hakamada K. Perioperative blood transfusion as a poor prognostic factor after aggressive surgical resection for hilar cholangiocarcinoma. J Gastrointest Surg 2015;19:866-79. [PMID: 25605416 DOI: 10.1007/s11605-014-2741-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
28 Nagino M, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Kondo S, Furuse J, Saito H, Tsuyuguchi T, Yoshikawa T. Preoperative biliary drainage for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008;15:25-30. [PMID: 18274841 DOI: 10.1007/s00534-007-1277-7] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
29 Otani K, Chijiiwa K, Kai M, Ohuchida J, Nagano M, Tsuchiya K, Kondo K. Outcome of surgical treatment of hilar cholangiocarcinoma. J Gastrointest Surg. 2008;12:1033-1040. [PMID: 18085342 DOI: 10.1007/s11605-007-0453-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
30 Jarnagin WR, Bowne W, Klimstra DS, Ben-Porat L, Roggin K, Cymes K, Fong Y, DeMatteo RP, D'Angelica M, Koea J, Blumgart LH. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 2005;241:703-12; discussion 712-4. [PMID: 15849506 DOI: 10.1097/01.sla.0000160817.94472.fd] [Cited by in Crossref: 141] [Cited by in F6Publishing: 109] [Article Influence: 8.8] [Reference Citation Analysis]
31 Nimura Y. Radical surgery of left-sided klatskin tumors. HPB (Oxford). 2008;10:168-170. [PMID: 18773047 DOI: 10.1080/13651820801992674] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
32 Buettner S, van Vugt JL, IJzermans JN, Groot Koerkamp B. Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther. 2017;10:1131-1142. [PMID: 28260927 DOI: 10.2147/ott.s93629] [Cited by in Crossref: 58] [Cited by in F6Publishing: 16] [Article Influence: 14.5] [Reference Citation Analysis]
33 Kennedy TJ, Yopp A, Qin Y, Zhao B, Guo P, Liu F, Schwartz LH, Allen P, D’Angelica M, Fong Y. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford). 2009;11:445-451. [PMID: 19768150 DOI: 10.1111/j.1477-2574.2009.00090.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 70] [Article Influence: 8.8] [Reference Citation Analysis]
34 Valero V 3rd, Cosgrove D, Herman JM, Pawlik TM. Management of perihilar cholangiocarcinoma in the era of multimodal therapy. Expert Rev Gastroenterol Hepatol 2012;6:481-95. [PMID: 22928900 DOI: 10.1586/egh.12.20] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
35 Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ashida R, Ohgi K, Nakagawa M, Uesaka K. Left Hepatectomy with Combined Resection and Reconstruction of Right Hepatic Artery for Bismuth Type I and II Perihilar Cholangiocarcinoma. World J Surg 2019;43:894-901. [PMID: 30377720 DOI: 10.1007/s00268-018-4833-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
36 Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol. 2009;15:4240-4262. [PMID: 19750567 DOI: 10.3748/wjg.15.4240] [Cited by in CrossRef: 173] [Cited by in F6Publishing: 147] [Article Influence: 14.4] [Reference Citation Analysis]
37 Petrowsky H, Clavien PA. Should we deny surgery for malignant hepato-pancreatico-biliary tumors to elderly patients? World J Surg 2005;29:1093-100. [PMID: 16086216 DOI: 10.1007/s00268-005-1130-6] [Cited by in Crossref: 65] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
38 Kloek JJ, Ten Kate FJ, Busch OR, Gouma DJ, van Gulik TM. Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) 2008;10:190-5. [PMID: 18773053 DOI: 10.1080/13651820801992575] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
39 Xiong JJ, Nunes QM, Huang W, Pathak S, Wei AL, Tan CL, Liu XB. Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy. World J Gastroenterol. 2013;19:8731-8739. [PMID: 24379593 DOI: 10.3748/wjg.v19.i46.8731] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
40 Anaya DA, Blazer DG, Abdalla EK. Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma. Semin Intervent Radiol 2008;25:110-22. [PMID: 21326552 DOI: 10.1055/s-2008-1076684] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
41 Quyn AJ, Ziyaie D, Polignano FM, Tait IS. Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma. HPB (Oxford). 2009;11:570-577. [PMID: 20495709 DOI: 10.1111/j.1477-2574.2009.00102.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
42 Ruys AT, van Haelst S, Busch OR, Rauws EA, Gouma DJ, van Gulik TM. Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients. World J Surg. 2012;36:2179-2186. [PMID: 22569746 DOI: 10.1007/s00268-012-1638-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
43 Umeda J, Itoi T. Current status of preoperative biliary drainage. J Gastroenterol 2015;50:940-54. [DOI: 10.1007/s00535-015-1096-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
44 Kloek JJ, van der Gaag NA, Aziz Y, Rauws EA, van Delden OM, Lameris JS, Busch OR, Gouma DJ, van Gulik TM. Endoscopic and percutaneous preoperative biliary drainage in patients with suspected hilar cholangiocarcinoma. J Gastrointest Surg. 2010;14:119-125. [PMID: 19756881 DOI: 10.1007/s11605-009-1009-1] [Cited by in Crossref: 101] [Cited by in F6Publishing: 85] [Article Influence: 8.4] [Reference Citation Analysis]
45 Yasukawa K, Shimizu A, Motoyama H, Kubota K, Notake T, Fukushima K, Ikehara T, Hayashi H, Kobayashi A, Soejima Y. Impact of Remnant Carcinoma in Situ at the Ductal Stump on Long-Term Outcomes in Patients with Distal Cholangiocarcinoma. World J Surg 2021;45:291-301. [PMID: 32989580 DOI: 10.1007/s00268-020-05799-2] [Reference Citation Analysis]
46 Grünhagen DJ, Dunne DF, Sturgess RP, Stern N, Hood S, Fenwick SW, Poston GJ, Malik HZ. Metal stents: a bridge to surgery in hilar cholangiocarcinoma. HPB (Oxford) 2013;15:372-8. [PMID: 23458664 DOI: 10.1111/j.1477-2574.2012.00588.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
47 Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg 2014;399:693-705. [PMID: 24841192 DOI: 10.1007/s00423-014-1210-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
48 Jo JH, Chung MJ, Han DH, Park JY, Bang S, Park SW, Song SY, Chung JB. Best options for preoperative biliary drainage in patients with Klatskin tumors. Surg Endosc. 2017;31:422-429. [PMID: 27287904 DOI: 10.1007/s00464-016-4993-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 5.2] [Reference Citation Analysis]
49 Shimura T, Kofunato Y, Okada R, Yashima R, Koyama Y, Araki K, Kuwano H, Takenoshita S. Intranuclear accumulation of galectin-3 is an independent prognostic factor for patients with distal cholangiocarcinoma. Oncol Lett 2017;14:819-29. [PMID: 28693238 DOI: 10.3892/ol.2017.6252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
50 Patel T. Cholangiocarcinoma--controversies and challenges. Nat Rev Gastroenterol Hepatol. 2011;8:189-200. [PMID: 21460876 DOI: 10.1038/nrgastro.2011.20] [Cited by in Crossref: 204] [Cited by in F6Publishing: 181] [Article Influence: 20.4] [Reference Citation Analysis]
51 Hong SS, Han DH, Choi GH, Choi JS. Comparison study for surgical outcomes of right versus left side hemihepatectomy to treat hilar cholangiocellular carcinoma. Ann Surg Treat Res 2020;98:15-22. [PMID: 31909046 DOI: 10.4174/astr.2020.98.1.15] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 Kingham TP, Aveson VG, Wei AC, Castellanos JA, Allen PJ, Nussbaum DP, Hu Y, D'Angelica MI. Surgical management of biliary malignancy. Curr Probl Surg 2021;58:100854. [PMID: 33531120 DOI: 10.1016/j.cpsurg.2020.100854] [Reference Citation Analysis]
53 Bhardwaj N, Garcea G, Dennison AR, Maddern GJ. The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade? World J Surg 2015;39:2748-56. [PMID: 26133907 DOI: 10.1007/s00268-015-3125-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
54 Kwon HJ, Kim SG, Chun JM, Lee WK, Hwang YJ. Prognostic factors in patients with middle and distal bile duct cancers. World J Gastroenterol 2014;20:6658-65. [PMID: 24914391 DOI: 10.3748/wjg.v20.i21.6658] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
55 Liu S, Liu X, Li X, Li O, Yi W, Khan J, Yang P, Guo C, Peng C, Jiang B. Application of Laparoscopic Radical Resection for Type III and IV Hilar Cholangiocarcinoma Treatment. Gastroenterol Res Pract 2020;2020:1506275. [PMID: 32184814 DOI: 10.1155/2020/1506275] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
56 Furusawa N, Kobayashi A, Yokoyama T, Shimizu A, Motoyama H, Miyagawa S. Surgical Treatment of 144 Cases of Hilar Cholangiocarcinoma Without Liver-Related Mortality. World J Surg 2014;38:1164-76. [DOI: 10.1007/s00268-013-2394-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
57 Cillo U, Fondevila C, Donadon M, Gringeri E, Mocchegiani F, Schlitt HJ, Ijzermans JNM, Vivarelli M, Zieniewicz K, Olde Damink SWM, Groot Koerkamp B. Surgery for cholangiocarcinoma. Liver Int 2019;39 Suppl 1:143-55. [PMID: 30843343 DOI: 10.1111/liv.14089] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 40.0] [Reference Citation Analysis]
58 Ito T, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Shimoyama Y, Nagino M. The pathologic correlation between liver and portal vein invasion in perihilar cholangiocarcinoma: evaluating the oncologic rationale for the American Joint Committee on Cancer definitions of T2 and T3 tumors. World J Surg 2014;38:3215-21. [PMID: 25123177 DOI: 10.1007/s00268-014-2719-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
59 Noji T, Miyamoto M, Kubota KC, Shinohara T, Ambo Y, Matsuno Y, Kashimura N, Hirano S. Evaluation of extra capsular lymph node involvement in patients with extra-hepatic bile duct cancer. World J Surg Oncol 2012;10:106. [PMID: 22681770 DOI: 10.1186/1477-7819-10-106] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
60 Kim KM, Park JW, Lee JK, Lee KH, Lee KT, Shim SG. A Comparison of Preoperative Biliary Drainage Methods for Perihilar Cholangiocarcinoma: Endoscopic vs Percutaneous Transhepatic Biliary Drainage. Gut Liver. 2015;9:791-799. [PMID: 26087784 DOI: 10.5009/gnl14243] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
61 Goere D, Wagholikar GD, Pessaux P, Carrère N, Sibert A, Vilgrain V, Sauvanet A, Belghiti J. Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc. 2006;20:721-725. [PMID: 16508808 DOI: 10.1007/s00464-005-0583-x] [Cited by in Crossref: 116] [Cited by in F6Publishing: 86] [Article Influence: 7.7] [Reference Citation Analysis]
62 Chauhan A, House MG, Pitt HA, Nakeeb A, Howard TJ, Zyromski NJ, Schmidt CM, Ball CG, Lillemoe KD. Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma. HPB (Oxford). 2011;13:139-147. [PMID: 21241432 DOI: 10.1111/j.1477-2574.2010.00262.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
63 Rerknimitr R, Kullavanijaya P. Operable malignant jaundice: To stent or not to stent before the operation? World J Gastrointest Endosc. 2010;2:10-14. [PMID: 21160672 DOI: 10.4253/wjge.v2.i1.10] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
64 Wu WG, Gu J, Dong P, Lu JH, Li ML, Wu XS, Yang JH, Zhang L, Ding QC, Weng H, Ding Q, Liu YB. Duct-to-duct biliary reconstruction after radical resection of Bismuth IIIa hilar cholangiocarcinoma. World J Gastroenterol 2013;19:2441-4. [PMID: 23613642 DOI: 10.3748/wjg.v19.i15.2441] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
65 Moole H, Tathireddy H, Dharmapuri S, Moole V, Boddireddy R, Yedama P, Uppu A, Bondalapati N, Duvvuri A. Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: A systematic review and meta-analysis. World J Gastroenterol. 2017;23:1278-1288. [PMID: 28275308 DOI: 10.3748/wjg.v23.i7.1278] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 27] [Article Influence: 10.5] [Reference Citation Analysis]
66 Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ. Surgical management of hilar cholangiocarcinoma. Ann Surg. 2005;241:693-699; discussion 699-702. [PMID: 15849505 DOI: 10.1097/01.sla.0000160701.38945.82] [Cited by in Crossref: 245] [Cited by in F6Publishing: 205] [Article Influence: 15.3] [Reference Citation Analysis]
67 Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J, Hauss J, Wiedmann M. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg. 2006;244:230-239. [PMID: 16858185 DOI: 10.1097/01.sla.0000217639.10331.47] [Cited by in Crossref: 201] [Cited by in F6Publishing: 153] [Article Influence: 13.4] [Reference Citation Analysis]
68 Han IW, Jang JY, Lee KB, Kang MJ, Kwon W, Park JW, Chang YR, Kim SW. Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin. HPB (Oxford) 2014;16:575-81. [PMID: 24308425 DOI: 10.1111/hpb.12193] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
69 Taniguchi K, Iida T, Hori T, Yagi S, Imai H, Shiraishi T, Uemoto S. Impact of lymph node micrometastasis in hilar bile duct carcinoma patients. World J Gastroenterol. 2006;12:2549-2555. [PMID: 16688800 DOI: 10.3748/wjg.v12.i16.2549] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
70 Malago M, Frilling A, Li J, Lang H, Broelsch CE. Cholangiocellular carcinoma--the role of caudate lobe resection and mesohepatectomy. HPB (Oxford). 2008;10:179-182. [PMID: 18773050 DOI: 10.1080/13651820801992500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
71 Öter V, Özer İ, Dalgıç T, Binarbaşı C, Ulaş M, Bostancı EB. Results of positive proximal margin after resection for hilar cholangiocarcinoma: An analysis of 42 cases. Turk J Gastroenterol 2019;30:88-94. [PMID: 30301710 DOI: 10.5152/tjg.2018.17752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
72 Olthof PB, Miyasaka M, Koerkamp BG, Wiggers JK, Jarnagin WR, Noji T, Hirano S, van Gulik TM. A comparison of treatment and outcomes of perihilar cholangiocarcinoma between Eastern and Western centers. HPB (Oxford). 2019;21:345-351. [PMID: 30087051 DOI: 10.1016/j.hpb.2018.07.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
73 van der Gaag NA, Kloek JJ, de Castro SM, Busch OR, van Gulik TM, Gouma DJ. Preoperative biliary drainage in patients with obstructive jaundice: history and current status. J Gastrointest Surg. 2009;13:814-820. [PMID: 18726134 DOI: 10.1007/s11605-008-0618-4] [Cited by in Crossref: 107] [Cited by in F6Publishing: 90] [Article Influence: 8.2] [Reference Citation Analysis]
74 Dinant S, Gerhards MF, Busch OR, Obertop H, Gouma DJ, Van Gulik TM. The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma. HPB (Oxford). 2005;7:263-267. [PMID: 18333204 DOI: 10.1080/13651820500372376] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
75 Sano T, Shimada K, Sakamoto Y, Yamamoto J, Yamasaki S, Kosuge T. One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg. 2006;244:240-247. [PMID: 16858186 DOI: 10.1097/01.sla.0000217605.66519.38] [Cited by in Crossref: 164] [Cited by in F6Publishing: 156] [Article Influence: 10.9] [Reference Citation Analysis]
76 Zhang W, Yan LN. Perihilar cholangiocarcinoma: Current therapy. World J Gastrointest Pathophysiol 2014;5:344-54. [PMID: 25133034 DOI: 10.4291/wjgp.v5.i3.344] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
77 Sano T, Shimizu Y, Senda Y, Kinoshita T, Nimura Y. Assessing resectability in cholangiocarcinoma. Hepat Oncol 2014;1:39-51. [PMID: 30190940 DOI: 10.2217/hep.13.6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
78 Seyama Y, Makuuchi M. Current surgical treatment for bile duct cancer. World J Gastroenterol 2007;13:1505-15. [PMID: 17461441 DOI: 10.3748/wjg.v13.i10.1505] [Cited by in CrossRef: 83] [Cited by in F6Publishing: 67] [Article Influence: 5.9] [Reference Citation Analysis]
79 Shimizu A, Motoyama H, Kubota K, Notake T, Fukushima K, Ikehara T, Hayashi H, Yasukawa K, Kobayashi A, Soejima Y. Safety and Oncological Benefit of Hepatopancreatoduodenectomy for Advanced Extrahepatic Cholangiocarcinoma with Horizontal Tumor Spread: Shinshu University Experience. Ann Surg Oncol. 2021;28:2012-2025. [PMID: 33044629 DOI: 10.1245/s10434-020-09209-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
80 Matull WR, Dhar DK, Ayaru L, Sandanayake NS, Chapman MH, Dias A, Bridgewater J, Webster GJ, Bong JJ, Davidson BR, Pereira SP. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer. Liver Int 2011;31:99-107. [PMID: 20846273 DOI: 10.1111/j.1478-3231.2010.02345.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
81 Lim JH, Choi GH, Choi SH, Kim KS, Choi JS, Lee WJ. Liver resection for Bismuth type I and Type II hilar cholangiocarcinoma. World J Surg. 2013;37:829-837. [PMID: 23354922 DOI: 10.1007/s00268-013-1909-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
82 Witzigmann H, Wiedmann M, Wittekind C, Mössner J, Hauss J. Therapeutical concepts and results for Klatskin tumors. Dtsch Arztebl Int 2008;105:156-61. [PMID: 19633782 DOI: 10.3238/arztebl.2008.0156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
83 Witzigmann H, Lang H, Lauer H. Guidelines for palliative surgery of cholangiocarcinoma. HPB (Oxford). 2008;10:154-160. [PMID: 18773044 DOI: 10.1080/13651820801992567] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
84 Sakamoto Y, Sano T, Shimada K, Kosuge T, Kimata Y, Sakuraba M, Yamamoto J, Ojima H. Clinical significance of reconstruction of the right hepatic artery for biliary malignancy. Langenbecks Arch Surg. 2006;391:203-208. [PMID: 16525853 DOI: 10.1007/s00423-006-0026-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
85 Ipek S, Alper E, Cekic C, Cerrah S, Arabul M, Aslan F, Unsal B. Evaluation of the effectiveness of endoscopic retrograde cholangiopancreatography in patients with perihilar cholangiocarcinoma and its effect on development of cholangitis. Gastroenterol Res Pract 2014;2014:508286. [PMID: 24982670 DOI: 10.1155/2014/508286] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
86 Cho MS, Kim SH, Park SW, Lim JH, Choi GH, Park JS, Chung JB, Kim KS. Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single-institution experience. J Gastrointest Surg 2012;16:1672-9. [PMID: 22798185 DOI: 10.1007/s11605-012-1960-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
87 Miyakawa S, Ishihara S, Takada T, Miyazaki M, Tsukada K, Nagino M, Kondo S, Furuse J, Saito H, Tsuyuguchi T. Flowcharts for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008;15:7-14. [PMID: 18274839 DOI: 10.1007/s00534-007-1275-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
88 Hasegawa S, Ikai I, Fujii H, Hatano E, Shimahara Y. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg. 2007;31:1256-1263. [PMID: 17453285 DOI: 10.1007/s00268-007-9001-y] [Cited by in Crossref: 129] [Cited by in F6Publishing: 120] [Article Influence: 9.2] [Reference Citation Analysis]
89 Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol. 2011;2:94-107. [PMID: 21603318 DOI: 10.5306/wjco.v2.i2.94] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
90 Liu F, Li Y, Wei Y, Li B. Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? Dig Dis Sci. 2011;56:663-672. [PMID: 20635143 DOI: 10.1007/s10620-010-1338-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 54] [Article Influence: 6.5] [Reference Citation Analysis]
91 Nooijen LE, Swijnenburg RJ, Klümpen HJ, Verheij J, Kazemier G, van Gulik TM, Erdmann JI. Surgical Therapy for Perihilar Cholangiocarcinoma: State of the Art. Visc Med 2021;37:18-25. [PMID: 33708815 DOI: 10.1159/000514032] [Reference Citation Analysis]
92 Xiang S, Lau WY, Chen XP. Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis. 2015;30:159-171. [PMID: 25376337 DOI: 10.1007/s00384-014-2063-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
93 Kurosaki I, Hatakeyama K, Minagawa M, Sato D. Portal vein resection in surgery for cancer of biliary tract and pancreas: special reference to the relationship between the surgical outcome and site of primary tumor. J Gastrointest Surg. 2008;12:907-918. [PMID: 17968629 DOI: 10.1007/s11605-007-0387-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
94 Lang H, Kaiser GM, Zöpf T, Sotiropoulos GC, Frilling A, Malagó M, Broelsch CE. [Surgical therapy of hilar cholangiocarcinoma]. Chirurg 2006;77:325-34. [PMID: 16568258 DOI: 10.1007/s00104-006-1177-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
95 Grendar J, Grendarova P, Sinha R, Dixon E. Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: a systematic review. HPB (Oxford) 2014;16:297-303. [PMID: 23981000 DOI: 10.1111/hpb.12150] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]